HISTOGENICS CORP Uncategorized Contracts & Agreements
31 Contracts & Agreements
- Third Amendment to the Co-Development and Commercialization Agreement, dated April 11, 2023, by and between the Registrant (Filed With SEC on April 16, 2024)
- First Amendment to the (Filed With SEC on February 28, 2023)
- Second Amendment to the Co-Development and Commercialization Agreement, dated November 21, 2022, by and between the Registrant and CanSino Biologics, Inc (Filed With SEC on February 28, 2023)
- Form of Non (Filed With SEC on February 28, 2023)
- Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 28, 2022)
- First Amendment to (Filed With SEC on November 9, 2021)
- Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 19, 2021)
- Form of In (Filed With SEC on March 27, 2020)
- Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 27, 2020)
- Co-Development and Commercialization Agreement, dated as of September 27, 2019, by and among the Registrant and CanSino Biologics Inc (Filed With SEC on November 12, 2019)
- Form of Lock-Up Agreement (Filed With SEC on June 14, 2019)
- Form of Series A/B Warrants (Filed With SEC on June 14, 2019)
- Form of Lock-Up Agreement, dated April 5, 2019, by each of the parties named in each agreement therein (Filed With SEC on April 8, 2019)
- FIRST AMENDMENT TO AGREEMENT (Filed With SEC on August 11, 2016)
- HISTOGENICS CORPORATION 830 Winter Street Waltham, MA 02451 January 30, 2015 (Filed With SEC on February 27, 2015)
- AMENDED AND RESTATED ROYALTY AGREEMENT (Filed With SEC on November 7, 2014)
- Additional abbreviationsmay also be used though not in the above list. For Value Received, hereby sell, assign and transfer unto (Filed With SEC on November 7, 2014)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on October 7, 2014)
- CONFIDENTIAL TREATMENT REQUESTED COLLAGEN TECHNOLOGY TRANSFER AGREEMENT (Filed With SEC on October 7, 2014)
- HISTOGENICS CORPORATION 830 Winter Street Waltham, MA 02451 February 28, 2014 (Filed With SEC on October 7, 2014)
- CONFIDENTIAL TREATMENT REQUESTED LICENCE AGREEMENT Between YEDA RESEARCH ANDDEVELOPMENT COMPANY LIMITED (Filed With SEC on October 7, 2014)
- AMENDMENT NO. 4 TO THELICENSE AGREEMENT EFFECTIVE 04/15/2001 BETWEEN STANFORD UNIVERSITY AND HISTOGENICS CORPORATION (Filed With SEC on October 7, 2014)
- CONFIDENTIAL TREATMENT REQUESTED SECOND AMENDMENT TO EXCLUSIVE AGREEMENT (Filed With SEC on October 7, 2014)
- FIRST AMENDMENT TO EXCLUSIVE AGREEMENT (Filed With SEC on October 7, 2014)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on October 7, 2014)
- CONFIDENTIAL TREATMENT REQUESTED AGREEMENT (Filed With SEC on October 7, 2014)
- CONFIDENTIAL TREATMENT REQUESTED AMENDMENT TO LICENSEAGREEMENT (1st Amendment) (Filed With SEC on October 7, 2014)
- Very truly yours, (Filed With SEC on October 7, 2014)
- INDEMNITY AGREEMENT (Filed With SEC on October 7, 2014)
- ROYALTY AGREEMENT (Filed With SEC on October 7, 2014)
- HISTOGENICS CORPORATION SECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT TABLE OF CONTENTS (Filed With SEC on October 7, 2014)
